In our hands, amplification of any of PDGFRA, KIT or VEGFR2 is found in nearly a quarter of glioblastoma cases, with individual genes ranging from 14–25%, which may itself be an underestimate due to sampling. The gene discussed is PDGFRA; the disease is glioblastoma.